Percheron Therapeutics CEO Dr James Garner On JustStocks Video As ATL1102 Study Completes Recruitment

Percheron Therapeutics Limited (ASX: PER) CEO Dr James Garner speaks with JustStocks Video as the company announced the successful completion of recruitment to its ongoing international phase IIb study of ATL1102 in the treatment of Duchenne muscular dystrophy.

Articles of Interest